ZA202201337B - Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium - Google Patents

Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium

Info

Publication number
ZA202201337B
ZA202201337B ZA2022/01337A ZA202201337A ZA202201337B ZA 202201337 B ZA202201337 B ZA 202201337B ZA 2022/01337 A ZA2022/01337 A ZA 2022/01337A ZA 202201337 A ZA202201337 A ZA 202201337A ZA 202201337 B ZA202201337 B ZA 202201337B
Authority
ZA
South Africa
Prior art keywords
bifidobacterium
casein
composition
application
promoting proliferation
Prior art date
Application number
ZA2022/01337A
Inventor
Lijun Chen
Bin Liu
Jun Ying Zhao
Tiemin Jiang
Weiming Zhou
Jiantao Li
Yanpin Liu
Weicang Qiao
Original Assignee
Beijing Sanyuan Foods Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Sanyuan Foods Co Ltd filed Critical Beijing Sanyuan Foods Co Ltd
Publication of ZA202201337B publication Critical patent/ZA202201337B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA2022/01337A 2019-07-11 2022-01-27 Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium ZA202201337B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/095620 WO2021003741A1 (en) 2019-07-11 2019-07-11 APPLICATION OF β-CASEIN A2 AND COMPOSITION THEREOF IN PROMOTING PROLIFERATION OF BIFIDOBACTERIUM

Publications (1)

Publication Number Publication Date
ZA202201337B true ZA202201337B (en) 2022-03-30

Family

ID=74114352

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/01337A ZA202201337B (en) 2019-07-11 2022-01-27 Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium

Country Status (2)

Country Link
WO (1) WO2021003741A1 (en)
ZA (1) ZA202201337B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023099750A1 (en) 2021-12-03 2023-06-08 N.V. Nutricia Nutritional composition for improving infant microbiota
CN114128758A (en) * 2021-12-14 2022-03-04 广东燕塘乳业股份有限公司 Short-time fermented high-fiber lactose-free pure A2 beta casein type fermented milk and preparation method thereof
WO2024056784A1 (en) 2022-09-14 2024-03-21 N.V. Nutricia Nutritional composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103315063A (en) * 2012-03-19 2013-09-25 基斯有限公司 Infant formula milk powder capable of preventing diseases
EP3542813A1 (en) * 2013-05-31 2019-09-25 The A2 Milk Company Limited Beta-casein a2 and prevention of inflammation of the bowel
ES2743194T3 (en) * 2013-07-12 2020-02-18 A2 Milk Co Ltd Beta-casein A2 and reduction or prevention of symptoms of lactose intolerance
CN103636798B (en) * 2013-12-03 2015-10-21 黑龙江省乳品工业技术开发中心 A kind of preparation method of cow-goat milk mixed-type infant formula milk powder

Also Published As

Publication number Publication date
WO2021003741A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
ZA202201337B (en) Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium
IL263238A (en) Composition of probiotics and digestive enzymes and method of preparing and using the same
EP3727405A4 (en) Composition comprising lactobacillus plantarum for preventing and/or treating mental illness
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EP3596103A4 (en) Compositions and methods involving probiotic molecules
EP3583219A4 (en) Probiotic compositions and uses thereof
SG11202004680UA (en) Cellular compositions and methods of treatment i
IL290910A (en) Modified tff2 polypeptides containing compositions and methods of use thereof
EP3630798A4 (en) Engineered polypeptides and their applications in synthesis of beta-hydroxy-alpha-amino acids
GB201905386D0 (en) Probiotic compositions and uses thereof
AU201714012S (en) Edible composition and platter thereof
EP3709808A4 (en) Compositions and methods of improving dietary phosphorus and calcium utilization in animals
EP3253396A4 (en) Probiotic compositions and methods of use
EP4025299A4 (en) Mixotrophic probiotic compositions and uses thereof in the treatment of bloating
EP4051017A4 (en) Probiotic compositions and methods
GB2524474B (en) Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes
IL286704A (en) Probiotic biofilm compositions and methods of preparing same
PL3454873T3 (en) Probiotic composition and uses thereof
ZA202007107B (en) Compositions comprising pcsk9-binding molecules and methods of use
GB201908154D0 (en) Lactobacillus compositions and uses thereof
GB201502240D0 (en) Composition and use of lactobacillus reuteri GMNL-263 in decreasing blood lipid levels
GB201905389D0 (en) Probiotic compositions and uses
GB201908706D0 (en) Lactobacillus compositions and uses thereof
GB201809947D0 (en) Probiotic compositions and uses thereof
IL311037A (en) Lactoferrin compositions and methods of use